Skip to Content

'
Abdulla Salahudeen, MD, MBA, MSc, FRCP

Present Title & Affiliation

Primary Appointment

Professor, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Director of Dialysis Unit, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Graduate Faculty, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2011 Texas Tech University Rawls College of Business, Lubbock, TX, MBA, Executive MBA, Business and Leadership
1983 University of Newcastle Upon Tyne,, Newcastle Upon Tyne, United Kingdom, MSc, Medicine
1976 Medical College, Trivandrum, India, MBBS, Medicine

Postgraduate Training

8/1988-12/1991 Clinical and Research Fellowship, Nephrology, University of Minnesota, Minneapolis, MN, under Professor T. Hostetter, MD and Professor K. A. Nath, M.D.
2/1983-7/1983 Registrar in Nephrology, Nephrology/Medicine, Freeman Hospital, University of Newcastle, Newcastle Upon Tyne, United Kingdom, under R. Wilkinson, MD
5/1980-1/1983 House Officer in Medicine, Royal Victoria Infirmary, Freeman Hospital, University of Newcastle, Newcastle Upon Tyne, United Kingdom, under Professor R. Wilkinson, MD
1/1977-3/1980 Medical Officer in Nephrology/Medicine, Nephrology Medicine, Central Hospital, Abu Dhabi, United Arab Emirates, under A. Pringle, MD
8/1975-7/1976 Clinical Internship, Medicine, Surgery, Obstetrics and Gynecology, and Pediatrics, Medical College, Trivandrum, India, under Professor D. V. Nair, MD

Board Certifications

1/2004 American Boards of Internal Medicine Nephrology
1/2003 American Boards of Internal Medicine
1988 Fellow of Royal College of Edinburgh (FRCP) of UK
1981 Member of Royal College of Physician (MRCP) of UK

Experience/Service

Administrative Appointments/Responsibilities

Chief, Section of Nephrology, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 8/2006-2/2012

Professional Memberships

AFMR National Executive Committee
Member, 2003-present
American Federation for Medical Research, IL
President, 2009-2010
American Federation for Medical Research
President-Elect, 2008-2009
American Society of Cancer Nephrology
Founding Member, 2010-present
American Society of Nephrology
Member, 1988-present
American Society of Transplantation
Member, 1994-present
Texas Medical Association
Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Doshi SD, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. American Journal of Kidney Disease 59:222-8, 2012.
2. Lahoti AL, Nates JL, Price KJ, Wakefield C, Salahudeen AK. Costs and outcomes of acute kidney injury in critically ill patients with cancer. The Journal of Supportive, 4/2011.
3. Mattiuzzi G, Lahoti A, Salahudeen A, Ravandi-Kashani F, Cortes J, Kantarjian H. An Assessment of the RIFLE Criteria for Acute Kidney Injury (AKI) and Morality in Patients (Pts) with Acute Myelogenous Leukmia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS), 9/2010.
4. Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, O'Brien S, Wierda W, Mattiuzzi GN. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 17(17):116, 9/2010. PMID: 20564156.
5. Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen AK, Shaw A. Small increases in serum creatinine are assoiciated with prolonged ICU stay and increased hospital mortality in ctirically ill patients with cancer. Support Cancer Care, 8/2010.
6. Salahudeen AK, May W. Reduction in cold ischemia time of renal allografts in the United States over the last decade. Transplant Proc 40(5):1285-9, 6/2008. PMCID: PMC2601678.
7. Salahudeen AK, Haider N, Jenkins J, Joshi M, Patel H, Huang H, Yang M, Zhe H. Anti-apoptotic Properties of Erythropoiesis Stimulating Proteins in Models of Cisplatin-Induced Acute Kidney Injury. Am J Physiol Renal Physiol 294(6):F1354-65, 4/2008. e-Pub 4/2008. PMID: 18385271.
8. Salahudeen AK. Fenoldopam Prophlaxis Works in Impending Acute Renal Failure Recruiting the non-hemodynamic Properties of fenoldopam. Internet Journal of Emergency & Intensive Care 10(1), 2008.
9. Schmidt DS, Salahudeen AK. Obesity-survival paradox-still a controversy? Semin Dial 20(6):486-92, Nov-Dec, 11/2007. PMID: 17991192.
10. Schmidt D, Salahudeen A. The obesity-survival paradox in hemodialysis patients: why do overweight hemodialysis patients live longer? Nutr Clin Pract 22(1):11-5, 2/2007. PMID: 17242449.
11. Stec DE, Bishop C, Rimoldi JM, Poreddy SR, Vera T, Salahudeen AK. Carbon monoxide (CO) protects renal tubular epithelial cells against cold-rewarm apoptosis. Ren Fail 29(5):543-8, 2007. PMID: 17654315.
12. Schmidt D, Salahudeen A. Obesity-survival paradox: in hemodialysis patients: why do overweight hemodialysis patients live longer? Nutr Clin Pract 22:11-15, 2007.
13. Miller VM, Lieske JC, Salahudeen AK. Introduction to pathologic calcification: crystallization, infection, or cellular transdifferentiation. J Investig Med. 54(7):365-6, 11/2006.
14. Salahudeen AK. The obesity paradox as it relates to survival and hypertension in dialysis patients. Nephrol Dial Transplant 21(6):1729; author reply 1729, 6/2006. e-Pub 3/17/2006. PMID: 16547121.
15. Kalantar-Zadeh K, Abbott KC, Salahudeen AK. Reverse epidemiology of obesity in dialysis patients: Fat or muscle? Am J Clin Nutrition 81(3):543-54, 2005.
16. Ahmad S, Salahudeen AK. Effect of obesity on PD versus HD survival: is caloric intake the discriminating factor? Kidney Int 66(2):866, 8/2004. PMID: 15253746.
17. Salahudeen AK. Consequences of cold ischemic injury of kidneys in clinical transplantation. J Investig Med 52(5):296-8, 7/2004. PMID: 15551651.
18. Salahudeen AK, Fleischmann EH, Bower JD, Hall JE. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population. Nephrol Dial Transplant 19(2):427-32, 2/2004. PMID: 14736969.
19. Salahudeen AK. Cold ischemic injury of transplanted organs: some new strategies against an old problem. Am J Transplant 4(1):1, 1/2004. PMID: 14678026.
20. Salahudeen A, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 52(2):296-298, 2004. PMID: 14717946.
21. Salahudeen AK, Dykes P, May W. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transplant 18(7):1339-44, 7/2003. PMID: 12808171.
22. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis 41(5):925-32, 5/2003. PMID: 12722026.
23. Huang H, He Z, Roberts LJ, Salahudeen AK. Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant 3(12):1531-1537, 3/2003. PMID: 14629283.
24. Salahudeen AK, Huang H, Manish J, Jenkins J. Involvement of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant 3(3):273-280, 2003. PMID: 12614281.
25. Crook ED, Thallapureddy A, Migdal S, Flack JM, Greene E L, Salahudeen A, Tucker JK, Taylor HA. Lipid abnormalities and renal disease: Is dyslipidemia a predictor of progression of renal disease? Am J Med Sci 325(6):340-348, 2003. PMID: 12811230.
26. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A 66(5):469-79, 2003. PMID: 12712633.
27. Salahudeen A, Dykes P, May W. Risk factors for higher mortality at the high end of Kt/V in dialysis patients. Nephrology, Dialysis, Transplantation 18:1339-1341, 2003.
28. Salahudeen AK. Lack of relationship between large body mass and survival on peritoneal dialysis: is it real? Perit Dial Int 22(5):634-5; author reply 635-6, Sep-Oct, 9/2002. PMID: 12455581.
29. Huang H, Salahudeen AK. Cold induces catalytic iron release of cytochrome P-450 origin: a critical step in cold storage-induced renal injury. Am J Transplant 2(7):631-9, 8/2002. PMID: 12201364.
30. Salahudeen AK, Joshi M, Jenkins JK. Apoptosis versus necrosis during cold storage and rewarming of human renal proximal tubular cells. Transplantation 72(5):798-804, 9/15/2001. PMID: 11571440.
31. Salahudeen AK, Fleischmann E, Ahmed A, Bower JD. Anemia and iron target realization in 1998: clinical management of anemia in 1,639 patients on hemodialysis. ASAIO J 47(5):511-5, Sep-Oct, 9/2001. PMID: 11575828.
32. Jenkins JK, Huang H, Ndebele K, Salahudeen AK. Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity. Transplantation 71(2):331-4, 1/2001. PMID: 11213082.
33. Bárány P, Stenvinkel P, Ottosson-Seeberger A, Alvestrand A, Morrow J, Roberts J. II, Salahudeen A. Effect of 6-Weeks of Vitamin E Administration on Renal Hemodynamic Alterations Following A Single Dose of Neoral in Healthy Volunteers. Nephrol Dial Transplantation 16:580-584, 2001.
34. Salahudeen A, Oliver B, Bower J, Roberts JL II. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int 60(4):1525-1531, 2001. PMID: 11576368.
35. Hong H, Patel P, Salahudeen A. Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: potential explanation for the lack of efficacy of Lazaroids in clinical trials. Pharmacol Res 43(1):55-61, 2001. PMID: 11207066.
36. Salahudeen A, Joshi M, Jenkins JK. Necrosis Vs. Apoptosis during Cold Storage and Rewarming of Human Renal Proximal Tubular Cells. Transplantation 72(5):798-804, 2001.
37. Salahudeen A, Hong H, Nedbele K, Jenkins J. Overexpression of Heme Oxygenase Protects Human Renal Tubular Cells Against Cold Storage Injury: Studies Utilizing Hemin Induction and hO-1 Gene Transfer. Transplantation 72:1498-504, 2001.
38. Fleischmann E, Bower J, Salahudeen A. Risk-Factor-Paradox in hemodialysis: Better Nutrition as a Partial Explanation. ASAIO J 47(1):74-81, Jan-Feb, 2001. PMID: 11199320.
39. Jenkins J, Hong H, Salahudeen A. Vitamin E suppresses Cyclosporine-A (CsA)-induced renal expression of COX II, TGF-beta 1 and osteopontin and nephrotoxicity in the rat. Transplantation 71:331-334, 2001.
40. Salahudeen A, Hong H, Patel M, Jenkins J. Mechanism and prevention of cold-induced human renal tubular cell injury. Transplantation 70:1424-1431, 2000.
41. Salahudeen A, Deogaygay B, Fleischmann E, Bower J. Race-based Survival Disparity on Hemodialysis: Higher Serum Aluminum as an Independent Risk Factor for the Higher Caucasian Mortality. Am J Kid Dis 36:1147-1154, 2000.
42. Poovala, VS, Hong H, Salahudeen A. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats. Am J Hypertension 12:492-498, 1999.
43. Salahudeen A, Navaz M, Poovala V, Wang C, Kanji V, Morrow, Roberts J. Cold storage induces time-dependent F2-isoprostane formation in renal tubular cells and rat kidneys. Kidney Int 55:1759-1762, 1999.
44. Salahudeen A, Fleischmann E, Bower J. Impact of underdialysis on overweight patients’ survival on hemodialysis. Kidney International 55:1560-1567, 1999.
45. Fleischmann E, Teal N, Dudley J, May W, Bower J, Salahudeen A. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999.
46. Poovala VS, Hong H, Salahudeen A. Role of reactive oxygen metabolities in organophosphate-Bidrin-induced renal tubular cytotoxicity. J Am Soc Nephrol 10:1746-1752, 1999.
47. Kanji VK, Wang C, Salahudeen A. Vitamin E suppresses Cyclosporine-a (CsA)-induced increase in urinary arachidonic acid metabolities including F2isoprostanes in the rat model. Transplant Proc 31:1724-1728, 1999.
48. Salahudeen A, Poovala P, Wilson P, Pande R, Kanji V, Ansari N, Morrow J, Roberts LJ. Cisplatin induces N-acetyl cysteine suppressible F2-isoprostanes production and injury in renal tubular cells. J Am soc Nephrol 9:1448-1455, 1998.
49. Salahudeen A. Effect of turmeric, turmerin and curcumin in H2O2-induced renal epithelial (LLC-PK1) cell injury. Free Radicals in Biology and Medicine 24:49-54, 1998.
50. Tachikawa H, Polask M, Huang JQ, Leszcynski J, Salahudeen A, Kwiatkowski S. Initiation reaction of lipid peroxidation: A Raman spectroscopic and Quantum-Mechanical Study. Applied Spectroscopy 52:1479-1482, 1998.
51. Poovala VS, Kanji VK, Tachikawa H, Salahudeen A. Role of oxidant stress and antioxidant protection in acephate-induced renal tubular cytotoxicity. Toxicol Sci 46(2):403-409, 1998. PMID: 10048144.
52. Reckelhoff JF, Kanji V, Racusen LC, Schmidt AM, Yan SD, Morrow J, Roberts LJ II, Salahudeen A. Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. Am J Physiol 274(3 Pt 2):R767-R774, 1998. PMID: 9530244.
53. Salahudeen A, Wang C, MaCDaniels O, Lagoo S, Bigler SA, Barber H. Antioxidant Lazaroid U-74006F Improves Renal Function And Reduces The Expression Of Cytokines, iNOS, And MHC Antigens In A Syngeneic Renal Transplant Model: Partial support for the response-to-injury hypothesis. Transplantation 62:1628-1633, 1996.
54. Salahudeen A, Wang C. Comparative study of the effect of 21-aminosteroid and alpha-tocopherol on models of acute oxidative renal injury. Free Radical Biology and Medicine 21:691-697, 1996.
55. Rao MJ, Kanji V, Wang C, Salahudeen A, Das SK, Cohly H. Cyclosporine-induced changes in NOS activity in the rat kidney: In-vitro and in-vivo assay. Indian J Physiol Pharmacol 40:183-185, 1996.
56. Rao RM, Kanji VK, Salahudeen A, Wang C. Inhibition of rat brain nitric oxide synthase activity by cyclosporine-A. Indian Journal of Experimental Biology 34:1265-1267, 1996.
57. Salahudeen A, Wang C, Bigler S, Dai Z, Tachikawa H. Synergistic renal protection by combining alkaline-diuresis with lipid peroxidation inhibitors in rhabdomyolysis: Possible interaction between oxidant and non-oxidant mechanisms. Nephrol Dial Transplant 21:691-697, 1996.
58. Rosenberg ME, Salahudeen A, Hostetter TH. Dietary protein and the renin-angiotensin system in chronic renal allograft rejection. Kidney Int 45:102-106, 1995.
59. Salahudeen A, Badr K, Morrow J, Roberts J II. Hydrogen peroxide induces 21-aminosteroid-inhibitable F2-Isoprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol 6:1300-1303, 1995.
60. Wang C, Salahudeen A. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 49:927-934, 1995.
61. Salahudeen A. Role of lipid peroxidation in H202-induced renal epithelial (LLC-PK1) cell injury. Am J Physiol 37:F30-F38, 1995.
62. Wang C, Salahudeen A. Cyclosporine-nephrotoxicity: Attenuation by an antioxidant-inhibitor of lipid peroxidation in-vitro and in-vivo. Transplantation 58(8):940-946, 1994. PMID: 7940739.
63. Nath KA, Salahudeen A. Autoxidation of cysteine generates hydrogen peroxide: cytotoxicity and attenuation by pyruvate. Am J Physiol 264:F306-F314, 1993.
64. Salahudeen A, Hostetter TH, Raatz SK, Rosenberg ME. Effect of dietary protein on renal function, the renin-angiotensin system and nutritional status in patients with chronic renal transplant rejection. Kidney Int 41:183-190, 1992.
65. Nath KA, Salahudeen A, Clark EC, Hostetter MK, Hostetter TH. The role of cellular metabolites in progressive renal injury. Kidney Int 38:S109-S113, 1992.
66. Salahudeen A, Clark EC, Nath KA. Hydrogen peroxide-induced renal injury: A protective role for pyruvate in vitro and in vivo. J Clin Invest 88(6):1886-1893, 1991. PMCID: PMC295757.
67. Modena FM, Hostetter TH, Salahudeen A, Najarian JS, Matas AJ, Rosenberg ME. Progression of kidney disease in chronic renal transplant rejection. Transplantation 52(2):239-244, 1991. PMID: 1871796.
68. Salahudeen AK, Woods HF, Pingle A, Nur-El-Huda Suleyman M, Shakuntala K, Nandakumar M, Yahya TM, Daar AS. High mortality among recipients of bought living-unrelated donor kidneys. Lancet 336(8717):725-8, 9/1990. PMID: 1975900.
69. Nath KA, Salahudeen A. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 86(4):1179-1192, 1990. PMCID: PMC296848.
70. Salahudeen A, Thomas T.H., Sellars L., Tapster S., Keavey P., Farndon J.R., Johnston I.D., Wilkinson R. Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy. Clin Sci (Lond) 76(3):289-296, 1989. PMID: 2924521.
71. Salahudeen A, Varma S.R., D'Costa R., Pingle A., Karim T., Bari Z. Successful experience with Continuous Ambulatory Peritoneal Dialysis in an Arabian Gulf Country. Saudi Medical Journal 10:481-484, 1989.
72. Salahudeen A, Varma S.R., Karim T., Bari M.Z., Pingle A., D'Costa, R. Anaemia, ferritin, and vitamins in continuous ambulatory peritoneal dialysis. Lancet 1:1049, 1988.
73. Salahudeen A. Hypertension among UAE citizens. Emirates Medical Journal 5:52-58, 1987.
74. Salahudeen A. Renal artery stenosis, erythrocytosis and renal artery occlusion. Nephrol-Dial-Transplant 2:53-54, 1987.
75. Salahudeen A, Karim MT, Pingle A, Kazi NM. Fistulization of AV shunt vasculature in patients on hemodialysis. Emirates Medical Journal 4:121-125, 1986.
76. Salahudeen A, Wilkinson R, McAinsh J, Bateman DN. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. Br J Clin Pharmacol 18:457-460, 1984.
77. Salahudeen A, Keavey PM, Hawkins T, Wilkinson R. Is anemia during continuous ambulatory peritoneal dialysis really better than during hemodialysis? Lancet 2:1046-1049, 1983.

Invited Articles
1. Zalantar-Zadeh K, Abbott K, Salahudeen A, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutrition 81:543-554, 2005.
2. Salahudeen A. Cold ischemic injury of transplanted kidneys: New insights from experimental studies. Am J Physiol Renal Physiol 287(2):F181-F187, 2004. PMID: 15271685.
3. Salahudeen A. Obesity and survival on dialysis (in-deph Review). AM J Kid Dis 41:925-932, 2003.
4. Crook ED, Flack J, Salem M, Salahudeen A, Hall J. Primary Renal Disease as a Cardiovascular Risk Factor. Am J Med Sci 324(3):138-145, 2002. PMID: 12240711.
5. Salahudeen A. Free radicals in experimental kidney disease and transplantation. Saudi J Kidney Dis Transplant 10:137-143, 1999.
6. Salahudeen A, Reckelhoff JF, Morrow JD, Roberts LJ II. F2-Isoprostanes and the kidney. Drug News Perspect 11(5):287-290, 1998. PMID: 15616648.
7. Salahudeen A. Pathogenesis of diabetic nephropathy: A radical approach. Nephrol Dial Transplant 12:664, 1997.

Editorials
1. Salahudeen AK. Fenoldopam prophylaxis in acute renal failure: Are we putting heme oxygenase-1 to work? Int J Trauma and Critical Care 10:1, Internet Journal of Emergency and Intensive Care Medicine, 2008.
2. Salahudeen A. Cold ischemic injury of transplanted organs: Some new strategies for an old problem. Am J Transplantation 1:1-2, 2004.
3. Salahudeen A. Is it really good to be fat on dialysis? Nephrol Dial Transplant 18(7):1248-1252, 2003. PMID: 12808156.
4. Salahudeen A. Halting progression of renal failure: Consideration beyond angiotensin II inhibition. Nephrol Dial Transplant 17(11):1871-1873, 2002. PMID: 12401837.
5. Salahudeen A. Perchloroethylene-induced renal toxicity in dry cleaning workers: Is there a role for free radicals? Nephrology Dialysis Transplantation 13:1122-1124, 1998.
Other Articles
1. Mouhayar, E., Salahudeen, A. Hypertension in Cancer Patients. Texas Heart Institute Journal, 6/2011.
2. Salahudeen AK, Haider N, Jenkins J, et al. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. American Journal of Physiol Renal Physiol 294(6):1354-65, 2008.
3. Chudhuri C, Salahudeen A. Massive intracerebral hemorrhage in an amphetamine addict. Am J Med Sci 317:359-362, 1999.
4. Nawaz M, Crook E, Bower JD, Salahudeen A. Spinal abscess with cord compression. Images in nephrology. Nephrol Dial Transplant 12:842, 1997.
5. Perry W, Dhillon R, Salahudeen A. Carotid pseudoaneurysm from inadvertent carotid artery catheterization for hemodialysis. Nephrol Dial Transplant 11:1853-1855, 1996.
6. Salahudeen A, Pingle A, Barri Z. Unique arterial collaterals in the presence of renal and aortic occulsions. Nephrol Dial Transplant 51:559-560, 1989.
7. Salahudeen A, Pingle A. Perforation of superior vena cava by subclavian hemodialysis access cannula: a preventable commplication? Nephrol Dial Transplant 3:354-355, 1988.
8. Salahudeen A, Pingle A. Reversibility of captopril-induced renal insufficiency after prolonged use in an unusual case of renovascular hypertension. J Hum Hypertens 2:57-59, 1988.
9. Salahudeen A, Ellis HA. Osteomalacia due to ileal replacement of ureters: report of 2 cases. J Urol 131:355-357, 1985.
10. Salahudeen A, Sellers L, Murthy LN, Francis DM, Donnelly PK, Hawkins T, Wilkinson R. Extrarenal arteriovenous fistula: An unusual complication of percutaneous renal transplant biopsy. Nephron 37:64-65, 1984.
11. Salahudeen A, Keavey PM, Haekins T, Wilkinson R. Anemia in Dialysis. Lancet 1:1276, 1983.
12. Salahudeen A. When to change the transfer set in CAPD. Lancet 2:230, 1983.

Abstracts
1. Vikash Sinha, Ming Yang, Luis Vence and Abdulla Salahudeen. Tubular injury-based biomarkers predict toxic-acute kidney injury (AKI) prior to the rise in serum creatinine in a cisplatin-induced AKI model: Comparative analysis of Kidney Injury Molecule-1, Neutrophil Gelatinase-associated Lipocalin, and N-Acetyl-Glucosaminidase. American Society of Nephrology. In Press.
2. Madan N, Lahoti A, Samuels J, Salahudeen A. Nutritional parameters as predictors of survival in AKI patients with cancer on continuous renal replacement therapy utilizing C-SLED. American Society of Nephrology, 2008.
3. Jones N, Ha T, Glissen B, Salahudeen A. The extent of AKI from cisplatin as a single chemotherapeutic agent in the setting of a standard hydration protocol. American Society of Nephrology, 2008.
4. Niti Madan, S. Vikas Kumar, Amit Lahoti, Joseph Nates, Kristen Rice, Abdulla Salahudeen. Renal Replacement Therapy in Critically Ill Cancer Patients Using Continuous Sustained Low Efficiency Dialysis (C-SLED): Feasibility, Efficacy and Tolerability. Journal of the American Society of Nephrology 18(Abstract Issue):450A, 10/2007.
5. Yang M, Salahudeen A. Adenosine preconditioning protects human renal proximal tubular epithelial (HPTE) cells against cold hypoxic injury through A1 receptor dependent and independent mechanism. American Society of Nephrology, 6/2007.
6. Madan N, Kumar V, Lahoti A, Nates J, Price K, Salahudeen A. Renal replacement therapy in critically ill cancer patients using Continuous Sustained Low Efficiency Dialysis (C-SLED). American Society of Nephrology, 6/2007.
7. Lahoti A, Nates J, Samuels J, Wakefield C, Price K, Salahudeen A. RIFLE criteria for acute kidney injury correlates with hospital mortality in critically ill patients with cancer. American Society of Nephrology, 6/2007.
8. Nagarajarao N, Taylor H, Benjamin E, Taylor J. Sar[pmg D,Salahudeen A, Wilson J, Sonny GV, Fox C, Fox E. The relation of C-reactive protein to chronic kidney disease in African Americans: The Jackson Heart Study. American Heart Association, 5/2007.
9. Salahudeen A. Cold ischemia in DCD kidneys. American Transplant Congress, 2005.
10. Salahudeen A. Pump or not to pump: Old question, new answers. American Transplant Congress, 2005.
11. Salahudeen A. Persistence of cold ischemia time and of its negative consequences on renal allografts. American TRansplant Congress, 2004.
12. Haider N, Huang H, Joshi M, Salahudeen A. Aranesp suppressses cisplatin-induced renal injury through an anti-apoptotic mechanism in a rat model. J Am Soc Nephrol 14:273A, 2003.
13. Patel H, Bishop C, Huang H, Salahudeen A. Calcium, calpain and calpastatin in cold storage injury of human renal tubular epithelial cells. J Am Soc Nephrol 14:273A, 2003.
14. Huang H, Zhe H, Jenkins JK, Salahudeen A. Fenoldopam induces heme oxygenase-1 and markedly suppresses cold-ischemia-associated acute renal injury in a syngeneic kidney transplant model. J Am Soc Nephrol 14:273A, 2003.
15. Huang H. Stec DE, Salahudeen AK. Fenoldopam induces heme oxygenase-1 and markedly suppresses cold-ischemia-associated acute renal injury in a syngeneic kidney transplant model. Journal of the American Society of Nephrology 14:182A, 2003.
16. Salahudeen A, Bower J. Hemodialysis catheter related intracardiac thrombosis and its treatment with rtPA. National Kidney Foundation, 2001.
17. Salahudeen A. Influence of nutrition on serum phosphorous, calcium and calcium-phosphorous product and their effects on hemodialysis survival. National Kidney Foundation, 2001.

Book Chapters
1. Lahoti A, Salahudeen A,. Nephrological Issues. In: Critical Care Issues in Cancer Patients. Ed(s) E Manzullo, C Gonzlez. Springer Science. In Press.
2. Nath KA, Salahudeen A, Shah SV. Cellular and biochemical mechanisms in progressive renal disease. In: Current Nephrology. 16. Ed(s) Gornick HC, 1993.

Letters to the Editor
1. Kalantar-Zadeh K, Abbott KC, Salahudeen A. Reverse Epidemiology of Obesity in Dialysis Patients: Fat or Muscle? Am J Clin Nutrition. In Press.
2. Ahmed S, Salahudeen A. Unlike hemodialysis, obesity on peritoneal dialysis is not associated with better survival: Is caloric intake the discriminating factor? Kidney International 66:866, 2004.
3. Salahudeen A. Bitter pill it is, but frequent hemodialysis than thrice weekly may be the answer. Kidney International 63:1961-1962, 2003.
4. Salahudeen A. Lack of relationship between large body mass and survival on peritoneal dialysis: Is this real? Peritoneal Dialysis International 22:634-635, 2002.
5. Salahudeen A, Fleischmann E. The need for body weight-based prescription of hemodialysis rather than changing the hemodialysis-dose-measure from Kt/V to Kt. Kidney International 57:738-740, 2000.
6. Salahudeen A, D'Costa R, Pingle A. Defects and demeirits of the double bag system. Peritneal Dialysis Bulletin 7:106, 1987.
7. Salahudeen A, Keavey PM, Hawkins T. Red cell survival and erythrocyte iron utilization in patients on continuous ambulatory peritoneal diallysis. Clin Nephrol 21:247-248, 1984.

Grant & Contract Support

Title: A Prospective Study of Urinary Biomarkers for Acute Kidney Injury in Cancer Patients Receving Cisplatin Chemotherapy
Funding Source: NIH/FNIH
Role: Principal Investigator
Duration: 2/20/2013 - 2/19/2015
 
Title: Hyponatremia Registry Study
Funding Source: Otsuka
Role: Co-Investigator
Duration: 7/1/2011 - 10/31/2011
 
Title: Grant to set up a National Onconephrology Forum
Funding Source: Otsuka
Role: Founder and President
Duration: 10/1/2010 - present
 
Title: Translational Medical Research Symposia Series
Funding Source: AFMR
Role: Co-Investigator
Principal Investigator: Deborah Zucker, MD PhD
Duration: 7/1/2006 - 6/30/2011
 
Funding Source: NIH/NIDDK
Role: Consultant
Principal Investigator: Tachikawa
Duration: 1997 - 2001

Last updated: 3/11/2013